10.8.1
aDSM objectives
National TB Management Guidelines, 2018 Edition. Chapter 10, Programmatic and Clinical Management of Drug-Resistant TB.
Clinical description
- To reduce risks from drug-related harms in patients on second line treatment for drug-
resistant TB and to generate standardized aDSM data to enable causality assessment for SAEs, determine their frequency (rates) and detect signals.
- This will contribute to future policy updates on the use of such medicines
Need this without data?
The app holds every guideline on your device, with calculators, bookmarks and notes.